BNT162b2 mRNA COVID-19 vaccine-induced chilblain-like lesions reinforces the hypothesis of their relationship with SARS-CoV-2.
作者信息
Piccolo V, Bassi A, Argenziano G, Mazzatenta C, Cutrone M, Neri I, Grimalt R, Russo T
机构信息
Dermatology Unit, University of Campania Luigi Vanvitelli, Naples, Italy.
UO Dermatologia- Azienda USL Toscana Nordovest, Lucca, Italy.
出版信息
J Eur Acad Dermatol Venereol. 2021 Aug;35(8):e493-e494. doi: 10.1111/jdv.17320. Epub 2021 May 10.
Abstract
摘要
相似文献
1
BNT162b2 mRNA COVID-19 vaccine-induced chilblain-like lesions reinforces the hypothesis of their relationship with SARS-CoV-2.BNT162b2信使核糖核酸新冠疫苗诱发的冻疮样损伤强化了其与严重急性呼吸综合征冠状病毒2关系的假说。
J Eur Acad Dermatol Venereol. 2021 Aug;35(8):e493-e494. doi: 10.1111/jdv.17320. Epub 2021 May 10.
2
Chilblain-like lesions after BNT162b2 mRNA COVID-19 vaccine: a case report suggesting that 'COVID toes' are due to the immune reaction to SARS-CoV-2.BNT162b2 mRNA新冠疫苗接种后出现冻疮样病变：一例病例报告提示“新冠脚趾”是由对严重急性呼吸综合征冠状病毒2（SARS-CoV-2）的免疫反应所致
J Eur Acad Dermatol Venereol. 2021 Oct;35(10):e630-e632. doi: 10.1111/jdv.17451. Epub 2021 Jun 30.
3
Chilblain-like lesions onset during SARS-CoV-2 infection in a COVID-19-vaccinated adolescent: case report and review of literature.COVID-19 疫苗接种青少年在 SARS-CoV-2 感染期间出现冻疮样病变：病例报告及文献复习。
Ital J Pediatr. 2022 Jun 13;48(1):93. doi: 10.1186/s13052-022-01296-5.
4
Chilblain lesions after COVID-19 mRNA vaccine.新型冠状病毒肺炎信使核糖核酸疫苗接种后的冻疮样病变
Br J Dermatol. 2021 Jul;185(1):e3. doi: 10.1111/bjd.20060. Epub 2021 Apr 26.
5
Purpuric lesions on the eyelids developed after BNT162b2 mRNA COVID-19 vaccine: another piece of SARS-CoV-2 skin puzzle?BNT162b2 mRNA新冠疫苗接种后眼睑出现紫癜性病变：SARS-CoV-2皮肤谜题的又一拼图？
J Eur Acad Dermatol Venereol. 2021 Sep;35(9):e543-e545. doi: 10.1111/jdv.17340. Epub 2021 May 28.
6
Cutaneous reaction to BNT162b2 mRNA COVID-19 vaccine.BNT162b2 mRNA新冠疫苗的皮肤反应
Int J Dermatol. 2021 Jul;60(7):891-892. doi: 10.1111/ijd.15575. Epub 2021 Apr 14.
7
Analysis of COVID-19 Incidence and Severity Among Adults Vaccinated With 2-Dose mRNA COVID-19 or Inactivated SARS-CoV-2 Vaccines With and Without Boosters in Singapore.分析新加坡成年人接种 2 剂 mRNA COVID-19 或灭活 SARS-CoV-2 疫苗以及接种加强针后的 COVID-19 发病率和严重程度。
JAMA Netw Open. 2022 Aug 1;5(8):e2228900. doi: 10.1001/jamanetworkopen.2022.28900.
8
BNT162B2 mRNA COVID-19 Vaccine in Heart and Lung Transplanted Young Adults: Is an Alternative SARS-CoV-2 Immune Response Surveillance Needed?BNT162B2 mRNA新冠疫苗在心肺移植年轻成年人中的应用：是否需要另一种严重急性呼吸综合征冠状病毒2免疫反应监测方法？
Transplantation. 2022 Feb 1;106(2):e158-e160. doi: 10.1097/TP.0000000000003999.
9
Dynamics of antibody response to BNT162b2 mRNA COVID-19 vaccine after 6 months.6个月后对BNT162b2 mRNA新冠疫苗抗体反应的动态变化
J Travel Med. 2021 Dec 29;28(8). doi: 10.1093/jtm/taab173.
10
Pigmented purpuric dermatosis after BNT162B2 mRNA COVID-19 vaccine administration.BNT162B2 mRNA新冠疫苗接种后出现色素性紫癜性皮病
J Cosmet Dermatol. 2022 Feb;21(2):435-437. doi: 10.1111/jocd.14607. Epub 2021 Nov 17.
引用本文的文献
1
Cases of Pernio-Like Lesions after mRNA-1273 Vaccination with Clinical and Pathological Features: A Single-Center Experience.mRNA-1273疫苗接种后出现具有临床和病理特征的冻疮样病变病例：单中心经验
Ann Dermatol. 2023 Nov;35(Suppl 2):S281-S286. doi: 10.5021/ad.21.307.
2
SARS-CoV-2 Vaccination and Chilblain-like Lesions: What Do We Know so Far?新型冠状病毒2型疫苗接种与冻疮样病变：我们目前了解到了什么？
Dermatol Pract Concept. 2022 Oct 1;12(4):e2022170. doi: 10.5826/dpc.1204a170. eCollection 2022 Nov.
3
Cutaneous Reactions Following COVID-19 Vaccination: A Review of the Current Literature.新冠疫苗接种后的皮肤反应：当前文献综述
Clin Cosmet Investig Dermatol. 2022 Nov 6;15:2369-2382. doi: 10.2147/CCID.S388245. eCollection 2022.
4
Do we miss rare adverse events induced by COVID-19 vaccination?我们是否遗漏了由新冠病毒疫苗接种引起的罕见不良事件？
Front Med (Lausanne). 2022 Oct 10;9:933914. doi: 10.3389/fmed.2022.933914. eCollection 2022.
5
Epidemiology and clinical evolution of non-multisystem inflammatory syndrome (MIS-C) dermatological lesions in pediatric patients affected by SARS-CoV-2 infection: A systematic review of the literature.SARS-CoV-2 感染患儿非多系统炎症综合征（MIS-C）皮肤病损的流行病学和临床演变：文献系统回顾。
Eur J Pediatr. 2022 Oct;181(10):3577-3593. doi: 10.1007/s00431-022-04585-7. Epub 2022 Aug 10.
6
Global prevalence and clinical manifestations of cutaneous adverse reactions following COVID-19 vaccination: A systematic review and meta-analysis.新冠病毒疫苗接种后皮肤不良反应的全球流行率和临床表现：系统评价和荟萃分析。
J Eur Acad Dermatol Venereol. 2022 Nov;36(11):1947-1968. doi: 10.1111/jdv.18294. Epub 2022 Jun 21.
7
COVID-19 Vaccination Safety in Patients who have had SARS-CoV-2-induced Chilblains.新型冠状病毒感染后冻疮患者的新冠疫苗接种安全性
Acta Derm Venereol. 2022 Jun 9;102:adv00728. doi: 10.2340/actadv.v102.888.
8
COVID-19 vaccine development: milestones, lessons and prospects.COVID-19 疫苗研发：里程碑、经验教训与展望。
Signal Transduct Target Ther. 2022 May 3;7(1):146. doi: 10.1038/s41392-022-00996-y.
9
COVID-19 Vasculitis and vasculopathy-Distinct immunopathology emerging from the close juxtaposition of Type II Pneumocytes and Pulmonary Endothelial Cells.COVID-19 血管炎和血管病变-从 II 型肺泡细胞和肺内皮细胞的紧密并置中出现的独特免疫病理学。
Semin Immunopathol. 2022 May;44(3):375-390. doi: 10.1007/s00281-022-00928-6. Epub 2022 Apr 12.
10
Covid-19 and Covid-19 vaccine can slide along sides: a report of two cases of unilateral periflexural exanthema.新型冠状病毒肺炎及其疫苗可引发双侧皮疹：两例单侧屈侧周围性皮疹报告
J Eur Acad Dermatol Venereol. 2022 Aug;36(8):e595-e596. doi: 10.1111/jdv.18093. Epub 2022 Mar 28.
本文引用的文献
1
'Blue toes' following vaccination with the BNT162b2 mRNA COVID-19 vaccine.接种 BNT162b2 mRNA COVID-19 疫苗后出现“蓝色脚趾”。
J Travel Med. 2021 Jun 1;28(4). doi: 10.1093/jtm/taab024.
2
Chilblain-like lesions and COVID-19: second wave, second outbreak.冻疮样病变与新型冠状病毒肺炎：第二波，第二次爆发。
J Eur Acad Dermatol Venereol. 2021 May;35(5):e316-e318. doi: 10.1111/jdv.17145. Epub 2021 Mar 2.
3
Chilblain-Like Lesions during COVID-19 Pandemic: The State of the Art.2019冠状病毒病大流行期间的冻疮样病变：最新进展
Life (Basel). 2021 Jan 2;11(1):23. doi: 10.3390/life11010023.
4
Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine.BNT162b2 mRNA 新冠病毒疫苗的安全性和有效性。
N Engl J Med. 2020 Dec 31;383(27):2603-2615. doi: 10.1056/NEJMoa2034577. Epub 2020 Dec 10.
5
Clinical, Laboratory, and Interferon-Alpha Response Characteristics of Patients With Chilblain-like Lesions During the COVID-19 Pandemic.COVID-19 大流行期间冻疮样皮损患者的临床、实验室和干扰素-α反应特征。
JAMA Dermatol. 2021 Feb 1;157(2):202-206. doi: 10.1001/jamadermatol.2020.4324.
6
Dermoscopy of chilblain-like lesions during the COVID-19 outbreak: A multicenter study on 10 patients.新冠疫情期间冻疮样皮损的皮肤镜检查：一项针对10例患者的多中心研究
J Am Acad Dermatol. 2020 Dec;83(6):1749-1751. doi: 10.1016/j.jaad.2020.07.058. Epub 2020 Sep 30.
7
Robust T Cell Immunity in Convalescent Individuals with Asymptomatic or Mild COVID-19.无症状或轻症 COVID-19 康复者体内具有强大的 T 细胞免疫。
Cell. 2020 Oct 1;183(1):158-168.e14. doi: 10.1016/j.cell.2020.08.017. Epub 2020 Aug 14.
8
Chilblain-like lesions during the COVID-19 pandemic: should we really worry?新冠疫情期间的冻疮样病变：我们真的需要担心吗？
Int J Dermatol. 2020 Aug;59(8):1026-1027. doi: 10.1111/ijd.14993. Epub 2020 Jun 4.
9
Acral findings during the COVID-19 outbreak: Chilblain-like lesions should be preferred to acroischemic lesions.新型冠状病毒肺炎疫情期间的肢端表现：冻疮样病变较肢端缺血性病变更为常见。
J Am Acad Dermatol. 2020 Sep;83(3):e231. doi: 10.1016/j.jaad.2020.05.077. Epub 2020 May 22.
10
Chilblain-like lesions during COVID-19 epidemic: a preliminary study on 63 patients.新冠疫情期间的冻疮样病变：63例患者的初步研究
J Eur Acad Dermatol Venereol. 2020 Jul;34(7):e291-e293. doi: 10.1111/jdv.16526. Epub 2020 May 15.
Zotero 插件